Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.

@article{Boussios2016ManagementOP,
  title={Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.},
  author={Stergios Boussios and Esmeralda Seraj and George Zarkavelis and Dimitrios Petrakis and Aristomenes Kollas and Aikaterini Kafantari and Abraam Assi and Konstantina Tatsi and Nicholas Pavlidis and George Pentheroudakis},
  journal={Critical reviews in oncology/hematology},
  year={2016},
  volume={108},
  pages={164-174}
}
BACKGROUND Cervical cancer is the fourth most common cancer affecting women worldwide. Despite advances in screening and human papillomavirus (HPV) vaccination, a significant number of women present with or develop advanced disease. Palliative platinum-based chemotherapy (CT) is the standard first-line treatment for metastatic/recurrent cervical cancer. The prognosis remains poor and effective second line options are urgently needed. METHODS We searched the English-language medical literature… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…